Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 25, 2018 - Issue 3
2,112
Views
10
CrossRef citations to date
0
Altmetric
Original Article

A library of ATTR amyloidosis patient-specific induced pluripotent stem cells for disease modelling and in vitro testing of novel therapeutics

, , , , , , , ORCID Icon, , ORCID Icon, & show all
Pages 148-155 | Received 23 Mar 2018, Accepted 12 Jun 2018, Published online: 21 Jul 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sabrina Ghosh, Carlos Villacorta-Martin, Jonathan Lindstrom-Vautrin, Devin Kenney, Carly S. Golden, Camille V. Edwards, Vaishali Sanchorawala, Lawreen H. Connors, Richard M. Giadone & George J. Murphy. (2023) Mapping cellular response to destabilized transthyretin reveals cell- and amyloidogenic protein-specific signatures. Amyloid 30:4, pages 379-393.
Read now

Articles from other publishers (9)

Bernardo Bonilauri, Hye Sook Shin, Min Htet, Christopher D. Yan, Ronald M. Witteles, Karim Sallam & Joseph C. Wu. (2023) Generation of two induced pluripotent stem cell lines from patients with cardiac amyloidosis carrying heterozygous transthyretin (TTR) mutation. Stem Cell Research 72, pages 103215.
Crossref
Tarek Khedro, Jason M. Duran & Eric D. Adler. (2022) Modeling Nonischemic Genetic Cardiomyopathies Using Induced Pluripotent Stem Cells. Current Cardiology Reports 24:6, pages 631-644.
Crossref
Josef Blaszkiewicz & Stephen A. Duncan. (2022) Advancements in Disease Modeling and Drug Discovery Using iPSC-Derived Hepatocyte-like Cells. Genes 13:4, pages 573.
Crossref
Richard M. Giadone, Sabrina Ghosh & George J. Murphy. 2022. Novel Concepts in iPSC Disease Modeling. Novel Concepts in iPSC Disease Modeling 105 122 .
Alberto Posabella, Andrea B. Alber, Hendrik J. Undeutsch, Raoul A. Droeser, Anthony N. Hollenberg, Laertis Ikonomou & Darrell N. Kotton. (2021) Derivation of Thyroid Follicular Cells From Pluripotent Stem Cells: Insights From Development and Implications for Regenerative Medicine. Frontiers in Endocrinology 12.
Crossref
M. Teresa Donato, María Pelechá & Laia Tolosa. 2021. Recent Advances in iPSCs for Therapy, Volume 3. Recent Advances in iPSCs for Therapy, Volume 3 225 250 .
Richard M. Giadone, Derek C. Liberti, Taylor M. Matte, Jessica D. Rosarda, Celia Torres-Arancivia, Sabrina Ghosh, Jolene K. Diedrich, Sandra Pankow, Nicholas Skvir, J.C. Jean, John R. YatesIIIIII, Andrew A. Wilson, Lawreen H. Connors, Darrell N. Kotton, R. Luke Wiseman & George J. Murphy. (2020) Expression of Amyloidogenic Transthyretin Drives Hepatic Proteostasis Remodeling in an Induced Pluripotent Stem Cell Model of Systemic Amyloid Disease. Stem Cell Reports 15:2, pages 515-528.
Crossref
Joseph E. Kaserman, Killian Hurley, Mark Dodge, Carlos Villacorta-Martin, Marall Vedaie, Jyh-Chang Jean, Derek C. Liberti, Marianne F. James, Michelle I. Higgins, Nora J. Lee, George R. Washko, Raul San Jose Estepar, Jeffrey Teckman, Darrell N. Kotton & Andrew A. Wilson. (2020) A Highly Phenotyped Open Access Repository of Alpha-1 Antitrypsin Deficiency Pluripotent Stem Cells. Stem Cell Reports 15:1, pages 242-255.
Crossref
Ridwan Babatunde Ibrahim, Yo-Tsen Liu, Ssu-Yu Yeh & Jin-Wu Tsai. (2019) Contributions of Animal Models to the Mechanisms and Therapies of Transthyretin Amyloidosis. Frontiers in Physiology 10.
Crossref